Parallel Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,756
| Closed | -$83.2K | – | 3986 |
|
|
2026
Q1 | $83.2K | Hold |
5,756
| – | – | ﹤0.01% | 1695 |
|
|
2025
Q4 | $82K | Hold |
5,756
| – | – | ﹤0.01% | 1581 |
|
|
2025
Q3 | $45.4K | Buy |
5,756
+1,649
| +40% | +$11.7K | ﹤0.01% | 1839 |
|
|
2025
Q2 | $23.5K | Buy |
4,107
+2,377
| +137% | +$15.3K | ﹤0.01% | 2119 |
|
|
2025
Q1 | $14.1K | Sell |
1,730
-4,484
| -72% | -$41.5K | ﹤0.01% | 2297 |
|
|
2024
Q4 | $58.5K | Sell |
6,214
-42
| -0.7% | -$437 | ﹤0.01% | 1550 |
|
|
2024
Q3 | $66.8K | Hold |
6,256
| – | – | ﹤0.01% | 1453 |
|
|
2024
Q2 | $62.1K | Buy |
6,256
+90
| +1% | +$924 | ﹤0.01% | 1414 |
|
|
2024
Q1 | $72.6K | Buy |
6,166
+291
| +5% | +$3.72K | ﹤0.01% | 1318 |
|
|
2023
Q4 | $83.4K | Hold |
5,875
| – | – | ﹤0.01% | 1190 |
|
|
2023
Q3 | $71.4K | Sell |
5,875
-261
| -4% | -$3.37K | ﹤0.01% | 1233 |
|
|
2023
Q2 | $77.1K | Buy |
6,136
+50
| +0.8% | +$593 | ﹤0.01% | 1193 |
|
|
2023
Q1 | $67.5K | Sell |
6,086
-13
| -0.2% | -$160 | ﹤0.01% | 1225 |
|
|
2022
Q4 | $74.5K | Buy |
6,099
+2,562
| +72% | +$28.8K | ﹤0.01% | 1117 |
|
|
2022
Q3 | $37K | Buy |
3,537
+308
| +10% | +$3.43K | ﹤0.01% | 1393 |
|
|
2022
Q2 | $35K | Sell |
3,229
-132
| -4% | -$1.09K | ﹤0.01% | 1416 |
|
|
2022
Q1 | $32K | Hold |
3,361
| – | – | ﹤0.01% | 1498 |
|
|
2021
Q4 | $39K | Buy |
3,361
+3,229
| +2,446% | +$36K | ﹤0.01% | 1456 |
|
|
2021
Q3 | $1K | Hold |
132
| – | – | ﹤0.01% | 2853 |
|
|
2021
Q2 | $1K | Hold |
132
| – | – | ﹤0.01% | 2728 |
|
|
2021
Q1 | $1K | Hold |
132
| – | – | ﹤0.01% | 2614 |
|
|
2020
Q4 | $3K | Hold |
132
| – | – | ﹤0.01% | 2190 |
|
|
2020
Q3 | $2K | Hold |
132
| – | – | ﹤0.01% | 2294 |
|
|
2020
Q2 | $1K | Buy |
+132
| New | +$1.61K | ﹤0.01% | 2312 |
|
Other funds holding FOLD
Parallel Advisors's FOLD Position: Q2 2026 in Review
Parallel Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 5,756 shares — an estimated $83.2K sold.
Parallel Advisors first reported a position in FOLD in Q2 2020 and held it in 24 quarters. The position peaked at $83.4K in Q4 2023. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Parallel Advisors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Parallel Advisors sold 5,756 Amicus Therapeutics shares in Q2 2026, an estimated $83.2K.
- Parallel Advisors first reported a position in Amicus Therapeutics in Q2 2020 and held it in 24 quarters.
- Parallel Advisors's Amicus Therapeutics position peaked at $83.4K in Q4 2023.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.